Roflumilast Cream 0.05% Effective for Young Children with Atopic Dermatitis: Study Dr Riya Dave24 Feb 2025 9:00 PM ISTAccording to a Phase 3 clinical trial (INTEGUMENT-PED) roflumilast cream 0.05% is effective and safe for children aged 2-5 with mild-to-moderate...
Once-Daily Roflumilast Cream Shows Promising for Atopic Dermatitis: JAMA Dr Riya Dave13 Feb 2025 5:45 AM ISTA 0.15% once-daily roflumilast cream improved symptoms of atopic dermatitis (AD) across multiple endpoints, according to investigators of phase 3...
Roflumilast Cream Safe and Effective in Treatment of Atopic Dermatitis: JAMA Jacinthlyn Sylvia25 Sept 2024 8:00 PM ISTAccording to the recent study published in the Journal of American Medical Association, a new topical treatment for atopic dermatitis (AD) has been...
Conduct bridging CT, prove efficacy, safety: CDSCO Panel Tells Glenmark on Roflumilast Cream of additional strength, indication Dr. Divya Colin30 April 2024 6:00 PM ISTNew Delhi: Citing that Glenmark Limited should conduct bridging clinical trials to prove the efficacy and safety of the Roflumilast Cream 0.3%w/w...
FDA approves roflumilast cream for psoriasis among children aged 6 to 11 years Dr. Kamal Kant Kohli7 Oct 2023 10:15 AM ISTThe US Food and Drug Administration has expanded approval of roflumilast cream for children aged 6 to 11 years for treatment of psoriasis....
Arcutis Biotherapeutics eczema treatment cream Roflumilast met primary endpoints Isra Zaman21 Sept 2023 9:15 AM ISTArcutis Biotherapeutics announced that the INTEGUMENT-PED pivotal Phase 3 trial of roflumilast cream 0.05%, in children ages 2 to 5 years with mild to...
